CA2148256A1 - Compositions et methodes appropriees pour utilisation a des fins therapeutiques et pharmaceutiques - Google Patents

Compositions et methodes appropriees pour utilisation a des fins therapeutiques et pharmaceutiques

Info

Publication number
CA2148256A1
CA2148256A1 CA002148256A CA2148256A CA2148256A1 CA 2148256 A1 CA2148256 A1 CA 2148256A1 CA 002148256 A CA002148256 A CA 002148256A CA 2148256 A CA2148256 A CA 2148256A CA 2148256 A1 CA2148256 A1 CA 2148256A1
Authority
CA
Canada
Prior art keywords
pharmaceutically acceptable
acceptable composition
sulfate
composition according
containing component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002148256A
Other languages
English (en)
Inventor
Ralph M. Hart
Herman L. Jones
Veronica Lee Egelkrout
Sohail Malik
Margaret A. Kenny
Bernard Loev
James P. Harnisch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
C-P Technology LP
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2148256A1 publication Critical patent/CA2148256A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002148256A 1992-10-29 1993-10-28 Compositions et methodes appropriees pour utilisation a des fins therapeutiques et pharmaceutiques Abandoned CA2148256A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96979392A 1992-10-29 1992-10-29
US07/969,793 1992-10-29

Publications (1)

Publication Number Publication Date
CA2148256A1 true CA2148256A1 (fr) 1994-05-11

Family

ID=25516012

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002148256A Abandoned CA2148256A1 (fr) 1992-10-29 1993-10-28 Compositions et methodes appropriees pour utilisation a des fins therapeutiques et pharmaceutiques

Country Status (5)

Country Link
EP (1) EP0666750A1 (fr)
JP (1) JPH08502976A (fr)
AU (1) AU5589594A (fr)
CA (1) CA2148256A1 (fr)
WO (1) WO1994009798A1 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2081771B1 (es) * 1994-08-05 1996-10-01 Arredondo Javier Olaechea Composicion de un producto liquido de uso topico para quemaduras y golpes.
FR2725901B1 (fr) * 1994-10-25 1997-06-27 Thorel Jean Noel Utilisation du calcium en cosmetologie dans le traitement local des phenomenes irritatifs
FR2726187A1 (fr) * 1994-10-26 1996-05-03 Jean Noel Thorel Utilisation du calcium par voie topique dans le traitement local des dermatoses hyperproliferatives comme le psoriasis
US7404967B2 (en) 1994-12-21 2008-07-29 Cosmederm, Inc. Topical product formulations containing strontium for reducing skin irritation
DE69533842T2 (de) * 1994-12-21 2006-02-16 Cosmederm Technologies, La Jolla Formulierungen und verfahren zur verminderung von hautirritationen
EP0737471A3 (fr) * 1995-04-10 2000-12-06 L'oreal Utilisation d'un sel d'une métal alcalino-terreux comme inhibiteur de TNF-alpha dans une composition unique et composition obtenue
FR2732602B1 (fr) * 1995-04-10 1997-05-09 Oreal Utilisation d'un sel d'un metal alcalino-terreux dans une composition cosmetique ou pharmaceutique pour traiter les prurits
FR2732600B1 (fr) * 1995-04-10 1997-05-09 Oreal Utilisation d'un sel d'un metal alcalino-terreux dans une composition cosmetique et/ou dermatologique et composition obtenue
WO1996037207A2 (fr) * 1995-05-25 1996-11-28 Biofrontiers, Inc. Compositions pharmaceutiques contenant du sulfate de calcium
US5683725A (en) * 1995-05-25 1997-11-04 Biofrontiers, Inc. Modulation of substance P by compounds containing calcium sulfate and methods relating thereto
FR2740341B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, d'etain, de zinc, de manganese, d'yttrium, de cobalt, de baryum, de strontium dans une composition pour la peau
FR2740335B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, de lithium, d'etain, de zinc, de manganese ou d'yttrium comme antagoniste de substance p
GB9720061D0 (en) 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
US6436891B1 (en) 1999-02-19 2002-08-20 Mionix Corporation Adduct having an acidic solution of sparingly-soluble group IIA complexes
AU771148B2 (en) 1999-02-19 2004-03-18 Mionix Corporation Adduct having an acidic solution of sparingly-soluble group IIA complexes
JP2004510402A (ja) * 1999-02-19 2004-04-08 マイアニクス、コーパレイシャン 難溶性ｉｉａ族錯体の酸性溶液
WO2000056157A1 (fr) * 1999-03-22 2000-09-28 H.P.T. Research, Inc. Agent desinfectant
JP2001226210A (ja) * 2000-02-18 2001-08-21 Hozawa Hiroki 滅ウィルス剤およびその製造方法
EP1129715A1 (fr) * 2000-02-25 2001-09-05 Werner Dr. Reichen Utilisation de magnésium, de calcium et de silicium comme curatif des différentes maladies et pour le bien-être général
DE10025622A1 (de) * 2000-05-24 2001-11-29 Staatsbad Meinberg Gmbh Verfahren zur Herstellung eines kosmetischen Mittels aus Moorextrakt und Verfahren zur Herstellung des Moorextraktes
NO20014746D0 (no) 2001-09-28 2001-09-28 Clas M Kjoelberg Smertelindrende middel
TWI228051B (en) 2003-05-19 2005-02-21 Well Being Biochemical Corp Anti-bacterial, anti-viral, and anti-fungus composition, its preparation and use
US20060246148A1 (en) 2003-07-29 2006-11-02 Well-Being Biochemical Corp. Anti-bacterial, anti-virus, and anti-fungus composition, its preparation and use
US7087219B2 (en) * 2003-05-28 2006-08-08 Stanislaw R. Burzynski Toothpaste containing anticancer agents
EP1576880A1 (fr) * 2004-03-16 2005-09-21 Well-being Biochemical Corp. Composition antibactérienne, antivirale et antifongique, sa préparation et utilisation
FI119101B (fi) * 2006-01-24 2008-07-31 Medgenerics Oy Magnesiumsuoloja sisältävä hoitoaine kasvainten tai vastaavien hoitoon ja magnesiumsulfaatin käyttö
MY157620A (en) 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
GB2441499B (en) * 2006-09-08 2011-09-14 Jasin El Sammadoni Slimming Spray
GB0714670D0 (en) 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3584837D1 (de) * 1985-10-08 1992-01-16 Psori Med Ag Salzmischung zur behandlung der schuppenflechte (psoriasis) und anderer hautkrankheiten.
US4735802A (en) * 1986-05-05 1988-04-05 Le Bich N Topical dermatological composition and method of treatment
US4915936A (en) * 1988-10-31 1990-04-10 United States Gypsum Company Dental hygiene composition for reducing periodontal disease
WO1992016216A1 (fr) * 1991-03-16 1992-10-01 Torf Establishment Produits bioactifs derives de la tourbe, compositions pharmaceutiques et cosmetiques les contenant

Also Published As

Publication number Publication date
EP0666750A1 (fr) 1995-08-16
AU5589594A (en) 1994-05-24
JPH08502976A (ja) 1996-04-02
WO1994009798A1 (fr) 1994-05-11

Similar Documents

Publication Publication Date Title
CA2148256A1 (fr) Compositions et methodes appropriees pour utilisation a des fins therapeutiques et pharmaceutiques
Atherton Aloe vera: magic or medicine?
US5378461A (en) Composition for the topical treatment of skin damage
EP0112852B1 (fr) Composition de gel pharmaceutique
ES2415362T3 (es) Agente externo para tratar heridas
CA2105313A1 (fr) Compositions therapeutiques et cosmetiques pour le traitement de la peau
KR20100016450A (ko) 피부 외용제 조성물
JPH02502631A (ja) 乾癬に対する治療用組成物
HUT73791A (en) Compositions of oak bark extract, related synthetic compositions, and method of using same
US6267962B1 (en) Compositions and methods of treatment using peat derivatives
WO1992015276A2 (fr) Compositions therapeutiques et cosmetiques pour le traitement de la peau
JPS59112915A (ja) 抗炎症性組成物
US10383908B1 (en) Inducing granulation tissue in third-degree skin burns using topical Hamelia patens extract
Guthrie et al. Immunotherapy of non-clinical vaginal cancer
ES2824477T3 (es) Composición emoliente
CN114931611A (zh) 一种治疗烧烫伤、创伤病症的中药组合物及其制备方法
US20200147131A1 (en) Methods of treating basal cell carcinoma and glioblastoma
KR20170103380A (ko) 피부의 미백과 잔주름 개선용 조성물
US20060165611A1 (en) Composition for Treating and Preventing Periodontal Disease and Method of Use
RU2221550C1 (ru) Лекарственный препарат для лечения микробной экземы, парапроктита, ожогов, трофических язв и других вялозаживающих ран и способ получения препарата
US3067103A (en) Healing-enhancing preparations comprising gardenia florida seed extract and pharmaceutically acceptable carrier formulations
KR20020066242A (ko) 관절염 치료용 생약제제
CN107213238A (zh) 一种治疗毒蛇咬伤的中药及其制备方法
KR20100111061A (ko) 상처 치료용 조성물
JPH06509060A (ja) 皮膚を処置するための治療用および化粧用組成物

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued